Bermejo B - Search Results

1

Research-based PAM50 subtype predictor identifies higher responses and improved survival outcomes in HER2-positive breast cancer in the NOAH study.

Prat A, Bianchini G, Thomas M, Belousov A, Cheang MC, Koehler A, Gómez P, Semiglazov V, Eiermann W, Tjulandin S, Byakhow M, Bermejo B, Zambetti M, Vazquez F, Gianni L, Baselga J. Prat A, et al. Among authors: bermejo b. Clin Cancer Res. 2014 Jan 15;20(2):511-21. doi: 10.1158/1078-0432.CCR-13-0239. Clin Cancer Res. 2014. PMID: 24443618

2

Overexpression of c-erbB-2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy.

Felip E, Del Campo JM, Rubio D, Vidal MT, Colomer R, Bermejo B. Felip E, et al. Among authors: bermejo b. Cancer. 1995 Apr 15;75(8):2147-52. doi: 10.1002/1097-0142(19950415)75:8<2147::aid-cncr2820750818>3.0.co;2-8. Cancer. 1995. PMID: 7697606

3

Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.

Del Campo JM, Felip E, Rubio D, Vidal R, Bermejo B, Colomer R, Zanon V. Del Campo JM, et al. Among authors: bermejo b. Gynecol Oncol. 1994 Apr;53(1):27-32. doi: 10.1006/gyno.1994.1082. Gynecol Oncol. 1994. PMID: 8175018 Clinical Trial.

4

Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensity.

Ribas A, Albanell J, Bellmunt J, Solé-Calvo LA, Bermejo B, Gallardo E, Vidal R, Vera R, Eres N, Carulla J, Baselga J. Ribas A, et al. Among authors: bermejo b. J Clin Oncol. 1996 May;14(5):1573-80. doi: 10.1200/JCO.1996.14.5.1573. J Clin Oncol. 1996. PMID: 8622074 Clinical Trial.

5

M-CAVI, a neoadjuvant carboplatin-based regimen for the treatment of T2-4N0M0 carcinoma of the bladder.

Bellmunt J, Ribas A, Albanell J, Bermejo B, Vera R, De Torres JA, Morote J, Lopez-Pacios MA, Banus JM, Rovirosa A, Carulla J, Sole LA. Bellmunt J, et al. Among authors: bermejo b. Am J Clin Oncol. 1996 Aug;19(4):344-8. doi: 10.1097/00000421-199608000-00004. Am J Clin Oncol. 1996. PMID: 8677901 Clinical Trial.

6

Node-negative breast cancers with p53(-)/HER2-neu(-) status may identify women with very good prognosis.

Albanell J, Bellmunt J, Molina R, García M, Caragol I, Bermejo B, Ribas A, Carulla J, Gallego OS, Español T, Solé Calvo LA. Albanell J, et al. Among authors: bermejo b. Anticancer Res. 1996 Mar-Apr;16(2):1027-32. Anticancer Res. 1996. PMID: 8687094

7

Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma.

Bellmunt J, Ribas A, Eres N, Albanell J, Almanza C, Bermejo B, Solé LA, Baselga J. Bellmunt J, et al. Among authors: bermejo b. Cancer. 1997 Nov 15;80(10):1966-72. doi: 10.1002/(sici)1097-0142(19971115)80:10<1966::aid-cncr14>3.0.co;2-w. Cancer. 1997. PMID: 9366300 Clinical Trial.

8

Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients.

Chirivella I, Bermejo B, Insa A, Pérez-Fidalgo A, Magro A, Rosello S, García-Garre E, Martín P, Bosch A, Lluch A. Chirivella I, et al. Among authors: bermejo b. Breast Cancer Res Treat. 2009 Apr;114(3):479-84. doi: 10.1007/s10549-008-0018-1. Epub 2008 May 8. Breast Cancer Res Treat. 2009. PMID: 18463977

9

Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens.

Pérez-Fidalgo JA, Roselló S, García-Garré E, Jordá E, Martín-Martorell P, Bermejo B, Chirivella I, Guzman C, Lluch A. Pérez-Fidalgo JA, et al. Among authors: bermejo b. Breast Cancer Res Treat. 2010 Feb;120(1):245-51. doi: 10.1007/s10549-009-0426-x. Epub 2009 Jul 3. Breast Cancer Res Treat. 2010. PMID: 19575291

10

Outcome differences between patients with node-negative breast cancer classified according to the st. Gallen risk categories.

Blancas I, Gómez FJ, Bermejo B, Hennessy BT, Chirivella I, Magro A, Caballero A, Ferrer J, Valero V, Lluch A. Blancas I, et al. Among authors: bermejo b. Clin Breast Cancer. 2009 Nov;9(4):231-6. doi: 10.3816/CBC.2009.n.039. Clin Breast Cancer. 2009. PMID: 19933078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters